Sestant
UEI: RLA4S65GMH68
Overview
Awardee Type
Parent
(1 child)
Company Description
Kedrion’s plasma-derived therapies help people suffering from debilitating conditions like Hemophilia and Immune Deficiencies.
Name
Sestant
Headquarters
Fort Lee, NJ
United States
United States
Most Recent Award
Dec. 6, 2022
Calculating
Federal contract recipient
KEDRION BIOPHARMA INC
(UEI RLA4S65GMH68)
is headquartered in Fort Lee NJ.
Its primary registered NAICS is 325412 Pharmaceutical Preparation Manufacturing.
The corporation
was founded in June 2011 and
federally registered in
March 2012.
Federal Award Analysis
Sestant federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
This Parent entity does not have an associated active registration. Showing registration information for UEI UN3DCKKLHSE7 CAGE 6PRA7 instead.
Legal Name
KEDRION BIOPHARMA INC
UEI
UN3DCKKLHSE7
CAGE Code
6PRA7
Primary NAICS
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
June 6, 2011
Initial Registration
March 7, 2012
Last Registration
Jan. 2, 2025
Registration Activation
Jan. 5, 2024
Registration Expiration
Jan. 2, 2025
Fiscal Year End
December 31
Reported Entity Types
Foreign Owned
For Profit Organization
Manufacturer of Goods
For Profit Organization
Manufacturer of Goods
State of Incorporation
DE
Country of Incorporation
USA
Employees
>1500
Reported NAICS
Reported PSC
Accepts Credit Cards
No
People
Vendor contacts at Sestant
GSA Schedules and Price Lists
- Kedrion Biopharma
- PoP: 9/29/19 - 9/14/26
- Type: Pharmaceuticals and Drugs (FSS 65 I B)
- Obligated: $36,663